CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2092-6413
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia ; volume:51 ; number:1 ; day:11 ; month:1 ; year:2019 ; pages:1-15 ; date:1.2019
Experimental & molecular medicine ; 51, Heft 1 (11.1.2019), 1-15, 1.2019
- Creator
-
Jang, Woori
Park, Joonhong
Kwon, Ahlm
Choi, Hayoung
Kim, Jiyeon
Lee, Gun Dong
Han, Eunhee
Jekarl, Dong Wook
Chae, Hyojin
Han, Kyungja
Yoon, Jae-Ho
Lee, Seok
Chung, Nack-Gyun
Cho, Bin
Kim, Myungshin
Kim, Yonggoo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-018-0195-x
- URN
-
urn:nbn:de:101:1-2019021421142555192475
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jang, Woori
- Park, Joonhong
- Kwon, Ahlm
- Choi, Hayoung
- Kim, Jiyeon
- Lee, Gun Dong
- Han, Eunhee
- Jekarl, Dong Wook
- Chae, Hyojin
- Han, Kyungja
- Yoon, Jae-Ho
- Lee, Seok
- Chung, Nack-Gyun
- Cho, Bin
- Kim, Myungshin
- Kim, Yonggoo
- SpringerLink (Online service)
Other Objects (12)
FoxO3a Gene Down-regulation in Pathogenesis of Pediatric Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Acute lymphoblastic leukemia simulating breast carcinoma
Precision medicine in acute lymphoblastic leukemia
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia classification using persistent homology
Targeting chemokines for acute lymphoblastic leukemia therapy
Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome
FoxO3a Gene Down-regulation in Pathogenesis of Pediatric Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Acute lymphoblastic leukemia simulating breast carcinoma
Precision medicine in acute lymphoblastic leukemia
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia classification using persistent homology
Targeting chemokines for acute lymphoblastic leukemia therapy
Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome
FoxO3a Gene Down-regulation in Pathogenesis of Pediatric Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Acute lymphoblastic leukemia simulating breast carcinoma
Precision medicine in acute lymphoblastic leukemia
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia classification using persistent homology
Targeting chemokines for acute lymphoblastic leukemia therapy